Form 4: Erasca CFO and CBO David M. Chacko Reports Acquisition of Shares and Stock Options
SEC Form 4 Filing
David M. Chacko, CFO and CBO of Erasca, Inc., reports the acquisition of common stock and stock options.
Summary
- David M. Chacko, the CFO and CBO of Erasca, Inc., filed a Form 4 detailing changes in beneficial ownership.
- The report indicates the acquisition of 3,137 shares of common stock on June 14, 2024, and 12,324 shares on December 13, 2024, both at a price of $1.564 per share, through the company's 2021 Employee Stock Purchase Plan.
- Chacko also acquired options to purchase 800,000 shares of common stock at an exercise price of $1.76, vesting monthly starting February 1, 2025, and expiring on February 2, 2035.
- Following these transactions, Chacko directly owns 262,187 shares of common stock and options for 800,000 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and stock options by a key executive suggests confidence in the company's future, but it's a routine transaction.
Positives
- The acquisition of shares through the Employee Stock Purchase Plan indicates confidence in the company's future.
- The vesting schedule of the stock options incentivizes long-term commitment from the CFO and CBO.
Future Outlook
The vesting schedule of the stock options suggests a long-term commitment from the CFO and CBO to the company's success.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for insights into management's confidence in the company's prospects.
Comparison to Industry Standards
- Executive compensation packages, including stock options and employee stock purchase plans, are common in the biotechnology industry to attract and retain talent.
- Companies like Amgen, Gilead Sciences, and Regeneron Pharmaceuticals also utilize similar compensation strategies to align executive interests with shareholder value.
Stakeholder Impact
- The transactions may have a minor positive impact on shareholder sentiment, reflecting confidence from a key executive.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Acquisition of 3,137 shares of common stock. |
| 12/13/2024 | Acquisition of 12,324 shares of common stock. |
| 02/03/2025 | Date of stock option grant. |
| 02/01/2025 | Vesting start date for stock options. |
| 02/02/2035 | Expiration date for stock options. |
| 02/05/2025 | Date of Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Stock Options, Employee Stock Purchase Plan, Common Stock, ERAS, Erasca, Chacko, CFO, CBO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.